RxDoctor Payments Data

Marc Kallins, MD

Physical Medicine & Rehabilitation · Bradenton, FLNPI 1366437576

Payments from drug & device makers

$399in general payments, 2019–2025

Across 22 payments — averaging $18.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$130
  • Scilex Pharmaceuticals Inc.$76
  • Zyla Life Sciences, Inc.$61
  • Pfizer$33
  • GRT US Holding, Inc.$29
  • Electronic Waveform Lab, Inc.$25
  • plus $46 from 3 others

What the payments were for

  • Food & beverage$399100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Collegium Pharmaceutical, Inc.6$130
Scilex Pharmaceuticals Inc.4$76
Zyla Life Sciences, Inc.5$61
Pfizer2$33
GRT US Holding, Inc.1$29
Electronic Waveform Lab, Inc.1$25
Abbott1$17
Amgen1$15
Biodelivery Sciences International, Inc.1$14

How this compares

$399 in reported general payments places this provider in the 60th percentile of 618 physical medicine & rehabilitation providers in Florida.

See all physical medicine & rehabilitation providers in Florida

Medicare billing

Part B allowed, 2024
$233,066
Medicare patients
314
Services billed
2,654

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban13$7,717
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen32$361
Trazodone Hcl24$158
Atorvastatin Calcium30$144
Tamsulosin Hcl13$123
Gabapentin16$118
ClopidogrelClopidogrel Bisulfate17$69
Pantoprazole Sodium11$58
Lisinopril14$55
Tramadol Hcl12$38
Furosemide13$24

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$33$7,71713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 618 physical medicine & rehabilitation providers in Florida.

Other physical medicine & rehabilitation in Bradenton

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →